In a Friday note, Maybank analyst John Cheong says CHA is widely recognised as Korea’s leading expert in infertility, women’s health and maternity care, with 6,000 deliveries and 12,000 IVF cases annually.
SINGAPORE (Feb 17): Singapore Medical Group says a leading Korean healthcare group is taking a 8.8% strategic stake in the provider of premium specialist healthcare services.
CHA Medical Group will be subscribing to 30 million new SMG shares at 50 cents each or a 6% discount to its last closing price.
